Adverse renal and metabolic effects associated with oral sodium phosphate bowel preparation

Clinical Journal of the American Society of Nephrology

Volumn 3, Issue 5, 2008, Pages 1494-1503

  Heher, Eliot C ^a   Thier, Samuel O ^a,b   Rennke, Helmut ^c   Humphreys, Benjamin D ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LAXATIVE; PHOSPHATE; SODIUM DIHYDROGEN PHOSPHATE;

ADENOMA; BIOPSY; CHEMICALLY INDUCED DISORDER; COLON POLYP; COLONOSCOPY; COLORECTAL TUMOR; DOSE RESPONSE; EVIDENCE BASED MEDICINE; FAMILIAL HYPOPHOSPHATEMIC RICKETS; HUMAN; IMMUNOLOGY; KIDNEY CALCIFICATION; KIDNEY DISEASE; METABOLIC DISORDER; ORAL DRUG ADMINISTRATION; PATHOLOGY; PREOPERATIVE CARE; REVIEW; RISK FACTOR; TIME;

ADENOMA; ADMINISTRATION, ORAL; BIOPSY; CATHARTICS; COLONIC POLYPS; COLONOSCOPY; COLORECTAL NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; EVIDENCE-BASED MEDICINE; HUMANS; HYPOPHOSPHATEMIA, FAMILIAL; KIDNEY DISEASES; METABOLIC DISEASES; NEPHROCALCINOSIS; PHOSPHATES; PREOPERATIVE CARE; RISK FACTORS; TIME FACTORS;

EID: 53749102467     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.02040408     Document Type: Review

References (101)

1. Seeff LC, Richards TB, Shapiro JA, Nadel MR, Manninen DL, Given LS, Dong FB, Winges LD, McKenna MT: How many endoscopies are performed for colorectal cancer screening? Results from CDC's survey of endoscopic capacity. Gastroenterology 127: 1670-1677, 2004
2. Cram P, Fendrick AM, Inadomi J, Cowen ME, Carpenter D, Vijan S: The impact of a celebrity promotional campaign on the use of colon cancer screening: the Katie Couric effect. Arch Intern Med 163: 1601-1605, 2003
3. Rex DK, Imperiale TF, Latinovich DR, Bratcher LL: Impact of bowel preparation on efficiency and cost of colonoscopy. Am J Gastroenterol 97: 1696-1700, 2002
4. Johanson JF, Popp JW Jr, Cohen LB, Lottes SR, Forbes WP, Walker K, Carter E, Zhang B, Rose M: A randomized, multicenter study comparing the safety and efficacy of sodium phosphate tablets with 2L polyethylene glycol solution plus bisacodyl tablets for colon cleansing. Am J Gastroenterol 102: 2238-2246, 2007
5. American Society of Colon, Rectal Surgeons (ASCRS), American Society for Gastrointestinal Endoscopy (ASGE), Society of American Gastrointestinal, Endoscopic Surgeons (SAGES), Wexner SD, Beck DE, Baron TH, Fanelli RD, Hyman N, Shen B, Wasco KE: A consensus document on bowel preparation before colonoscopy: prepared by a task force from the American Society of Colon and Rectal Surgeons (ASCRS), the American Society for Gastrointestinal Endoscopy (ASGE), and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). Surg Endosc 20: 1147-1160, 2006
6. Bigard MA, Gaucher P, Lassalle C: Fatal colonic explosion during colonoscopic polypectomy. Gastroenterology 77: 1307-1310, 1979
7. Zanoni CE, Bergamini C, Bertoncini M, Bertoncini L, Garbini A: Whole-gut lavage for surgery: a case of intraoperative colonic explosion after administration of mannitol. Dis Colon Rectum 25: 580-581, 1982
8. Davis GR, Santa Ana CA, Morawski SG, Fordtran JS: Development of a lavage solution associated with minimal water and electrolyte absorption or secretion. Gastroenterology 78: 991-995, 1980
9. Fordtran JS, Santa Ana CA, Cleveland M: A low-sodium solution for gastrointestinal lavage. Gastroenterology 98: 11-16, 1990
10. Vanner SJ, MacDonald PH, Paterson WG, Prentice RS, Da Costa LR, Beck IT: A randomized prospective trial comparing oral sodium phosphate with standard polyethylene glycol-based lavage solution (Golytely) in the preparation of patients for colonoscopy. Am J Gastroenterol 85: 422-427, 1990
11. Kolts BE, Lyles WE, Achem SR, Burton L, Geller AJ, Mac-Math T: A comparison of the effectiveness and patient tolerance of oral sodium phosphate, castor oil, and standard electrolyte lavage for colonoscopy or sigmoidoscopy preparation. Am J Gastroenterol 88: 1218-1223, 1993
12. Hsu CW, Imperiale TF: Meta-analysis and cost comparison of polyethylene glycol lavage versus sodium phosphate for colonoscopy preparation. Gastrointest Endosc 48: 276-282, 1998
13. Tan JJ, Tjandra JJ: Which is the optimal bowel preparation for colonoscopy: a meta-analysis. Colorectal Dis 8: 247-258, 2006
14. http://www.phospho-soda.com/professionals/pdf/KeyFacts.pdf. Accessed January 10, 2008
15. Rex DK: Dosing considerations in the use of sodium phosphate bowel preparations for colonoscopy. Ann Pharmacother 41: 1466-1475, 2007
16. Ahmed M, Raval P, Buganza G: Oral sodium phosphate catharsis and acute renal failure. Am J Gastroenterol 91: 1261-1262, 1996
17. Schiller LR: Clinical pharmacology and use of laxatives and lavage solutions. J Clin Gastroenterol 28: 11-18, 1999
18. Fass R, Do S, Hixson LJ: Fatal hyperphosphatemia following fleet phospo-soda in a patient with colonic ileus. Am J Gastroenterol 88: 929-932, 1993
19. Fine A, Patterson J: Severe hyperphosphatemia following phosphate administration for bowel preparation in patients with renal failure: two cases and a review of the literature. Am J Kidney Dis 29: 103-105, 1997
20. Kirschbaum B: The acidosis of exogenous phosphate intoxication. Arch Intern Med 158: 405-408, 1998
21. Lieberman DA, Ghormley J, Flora K: Effect of oral sodium phosphate colon preparation on serum electrolytes in patients with normal serum creatinine. Gastrointest Endosc 43: 467-469, 1996
22. Aradhye S, Brensilver JM: Sodium phosphate-induced hy-pernatremia in an elderly patient: a complex pathophysiologic state. Am J Kidney Dis 18: 609-611, 1991
23. Patel V, Emmett M, Santa Ana CA, Fordtran JS: Pathogenesis of nephrocalcinosis after sodium phosphate catharsis to prepare for colonoscopy: intestinal phosphate absorption and its effect on urine mineral and electrolyte excretion. Hum Pathol 38: 193-194; author reply 194-195, 2007
24. Tan HL, Liew QY, Loo S, Hawkins R: Severe hyperphosphataemia and associated electrolyte and metabolic derangement following the administration of sodium phosphate for bowel preparation. Anaesthesia 57: 478-483, 2002
25. Frizelle FA, Colls BM: Hyponatremia and seizures after bowel preparation: report of three cases. Dis Colon Rectum 48: 393-396, 2005
26. Ayus JC, Levine R, Arieff AI: Fatal dysnatraemia caused by elective colonoscopy. BMJ 326: 382-384, 2003
27. Schroppel B, Segerer S, Keuneke C, Cohen CD, Schlondorff D: Hyponatremic encephalopathy after preparation for colonoscopy. Gastrointest Endosc 53: 527-529, 2001
28. Cohen CD, Keuneke C, Schiemann U, Schroppel B, Siegert S, Rascher W, Gross M, Schlondorff D: Hyponatraemia as a complication of colonoscopy. Lancet 357: 282-283, 2001
29. Turnage RH, Guice KS, Gannon P, Gross M: The effect of polyethylene glycol gavage on plasma volume. J Surg Res 57: 284-288, 1994
30. Granberry MC, White LM, Gardner SF: Exacerbation of congestive heart failure after administration of polyethylene glycol-electrolyte lavage solution. Ann Pharmacother 29: 1232-1235, 1995
31. Gumurdulu Y, Serin E, Ozer B, Gokcel A, Boyacioglu S: Age as a predictor of hyperphosphatemia after oral phosphosoda administration for colon preparation. J Gastroenterol Hepatol 19: 68-72, 2004
32. Clarkston WK, Tsen TN, Dies DF, Schratz CL, Vaswani SK, Bjerregaard P: Oral sodium phosphate versus sulfate-free polyethylene glycol electrolyte lavage solution in outpatient preparation for colonoscopy: a prospective comparison. Gastrointest Endosc 43: 42-48, 1996
33. Vukasin P, Weston LA, Beart RW: Oral fleet phospho-soda laxative-induced hyperphosphatemia and hypocalcemic tetany in an adult: report of a case. Dis Colon Rectum 40: 497-499, 1997
34. Biberstein M, Parker BA: Enema-induced hyperphosphatemia. Am J Med 79: 645-646, 1985
35. Korzets A, Dicker D, Chaimoff C, Zevin D: Life-threatening hyperphosphatemia and hypocalcemic tetany following the use of fleet enemas. J Am Geriatr Soc 40: 620-621, 1992
36. Ma KK, Ng CS, Mui LM, Chan KC, Ng EK, Chung SC: Severe hyperphosphatemia and hypocalcemia following sodium phosphate bowel preparation: a forgotten menace. Endoscopy 35: 717, 2003
37. Mishra R, Kaufman D, Mattern J 3rd, Dutta SK: Severe hyperphosphatemia and hypocalcemia caused by bowel preparation for colonoscopy using oral sodium phosphate in end-stage renal disease. Endoscopy 37: 1259-1260, 2005
38. Rohack JJ, Mehta BR, Subramanyam K: Hyperphosphatemia and hypocalcemic coma associated with phosphate enema. South Med J 78: 1241-1242, 1985
39. Ullah N, Yeh R, Ehrinpreis M: Fatal hyperphosphatemia from a phosphosoda bowel preparation. J Clin Gastroenterol 34: 457-458, 2002
40. Wechsler A, Schneider R, Sapojnikov M, Zamir D, Polyshuk I, Yagil Y: Bowel cleansing in patients with chronic renal failure: an often overlooked hazard. Nephrol Dial Transplant 21: 1133-1134, 2006
41. Aydogan T, Kanbay M, Uz B, Kaya A, Isik A, Bozalan R, Erkman M, Akcay A: Fatal hyperphosphatemia secondary to a phosphosoda bowel preparation in a geriatric patient with normal renal function. J Clin Gastroenterol 40: 177, 2006
42. Orias M, Mahnensmith RL, Perazella MA: Extreme hyperphosphatemia and acute renal failure after a phosphorus-containing bowel regimen. Am J Nephrol 19: 60-63, 1999
43. Eckstein J, Savic S, Eugster T, Pargger H, Gurke L, Pechula M, Steiger J, Mayr M: Extensive calcifications induced by hyperphosphataemia caused by phosphate-based enema in a patient after kidney transplantation. Nephrol Dial Transplant 21: 2013-2016, 2006
44. Keeffe EB: Colonoscopy preps: what's best? Gastrointest Endosc 43: 524-528, 1996
45. Di Palma JA, Brady CE 3rd: Colon cleansing for diagnostic and surgical procedures: polyethylene glycol-electrolyte lavage solution. Am J Gastroenterol 84: 1008-1016, 1989
46. Schwetz BA: From the Food and Drug Administration. JAMA 286: 2660, 2001
47. Desmeules S, Bergeron MJ, Isenring P: Acute phosphate nephropathy and renal failure. N Engl J Med 349: 1006-1007, 2003
48. Markowitz GS, Nasr SH, Mein P, Anderson H, Stack JI, Alterman L, Price B, Radhakrishnan J, D'Agati VD: Renal failure due to acute nephrocalcinosis following oral sodium phosphate bowel cleansing. Hum Pathol 35: 675-684, 2004
49. Markowitz GS, Stokes MB, Radhakrishnan J, D'Agati VD: Acute phosphate nephropathy following oral sodium phosphate bowel purgative: an underrecognized cause of chronic renal failure. J Am Soc Nephrol 16: 3389-3396, 2005
50. Aasebo W, Scott H, Ganss R: Kidney biopsies taken before and after oral sodium phosphate bowel cleansing. Nephrol Dial Transplant 22: 920-922, 2007
51. Gonlusen G, Akgun H, Ertan A, Olivero J, Truong LD: Renal failure and nephrocalcinosis associated with oral sodium phosphate bowel cleansing: clinical patterns and renal biopsy findings. Arch Pathol Lab Med 130: 101-106, 2006
52. Beyea A, Block C, Schned A: Acute phosphate nephropathy following oral sodium phosphate solution to cleanse the bowel for colonoscopy. Am J Kidney Dis 50: 151-154, 2007
53. Schattner A, Kopolovic J, Melzer E, Rapoport J: A 71-year-old woman with abdominal pain and acute renal failure. CMAJ 177: 454-455, 2007
54. Manley P, Somerfield J, Simpson I, Barber A, Zwi J: Bilateral uraemic optic neuritis complicating acute nephrocalcinosis. Nephrol Dial Transplant 21: 2957-2958, 2006
55. Brunelli SM, Lewis JD, Gupta M, Latif SM, Weiner MG, Feldman HI: Risk of kidney injury following oral phosphosoda bowel preparations. J Am Soc Nephrol 18: 3199-3205, 2007
56. Hurst FP, Bohen EM, Osgard EM, Oliver DK, Das NP, Gao SW, Abbott KC: Association of oral sodium phosphate purgative use with acute kidney injury. J Am Soc Nephrol 18: 3192-3198, 2007
57. Russmann S, Lamerato L, Marfatia A, Motsko SP, Pezzullo JC, Olds G, Jones JK: Risk of impaired renal function after colonoscopy: a cohort study in patients receiving either oral sodium phosphate or polyethylene glycol. Am J Gastroenterol 102: 2655-2663, 2007
58. Khurana A, McLean L, Atkinson S, Foulks CJ: The effect of oral sodium phosphate drug products on renal function in adults undergoing bowel endoscopy. Arch Intern Med 168: 593-597, 2008
59. Khurana A, McLean LB, Concepcion LA, Nickel AE, Foulks CJ: Acute phosphate nephropathy [poster 163A]. Presented at Renal Week: San Diego, CA, November 14-19, 2006
60. Ma RC, Chow CC, Yeung VT, So WY, Kong AP, Tong PC, Cockram. CS, Chan JC: Acute renal failure following oral sodium phosphate bowel preparation in diabetes. Diabetes Care 30: 182-183, 2007
61. Coe FL, Parks JH, Asplin JR: The pathogenesis and treatment of kidney stones. N Engl J Med 327: 1141-1152, 1992
62. Jennette JC, Olson JL, Schwartz MM, Silva FG: Heptinstall's Pathology of the Kidney, Philadelphia, Lippincott Williams & Wilkins, 1998, pp 893-895
63. Sayer JA, Carr G, Simmons NL: Nephrocalcinosis: molecular insights into calcium precipitation within the kidney. Clin Sci (Lond) 106: 549-561, 2004
64. Broyer M, Jouvet P, Niaudet P, Daudon M, Revillon Y: Management of oxalosis. Kidney Int Suppl 53[Suppil: 93-98, 1996
65. Singh A, Sarkar SR, Gaber LW, Perazella MA: Acute oxalate nephropathy associated with orlistat, a gastrointestinal lipase inhibitor. Am J Kidney Dis 49: 153-157, 2007
66. Asplin JR, Mandel NS, Coe FL: Evidence of calcium phosphate supersaturation in the loop of Henle. Am J Physiol 270: F604-F613, 1996
67. Evan AP, Lingeman JE, Coe FL, Parks JH, Bledsoe SB, Shao Y, Sommer AJ, Paterson RF, Kuo RL, Grynpas M: Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 111: 607-616, 2003
68. Prien EL: The riddle of Randall's plaques. J Urol 114: 500-507, 1975
69. Coe F, Parks JH: Defenses of an unstable compromise: crystallization inhibitors and the kidney's role in mineral regulation. Kidney Int 38: 625-631, 1990
70. Ettinger B, Tang A, Citron JT, Livermore B, Williams T: Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med 315: 1386-1389, 1986
71. Perazella MA: Crystal-induced acute renal failure. Am J Med 106: 459-465, 1999
72. Perazella MA: Tissue deposition of gadolinium and development of NSF: a convergence of factors. Semin Dial 21: 150-154, 2008
73. Kay J, Bazari H, Avery LL, Koreishi AF: Case records of the Massachusetts General Hospital (case 6-2008): a 46-year-old woman with renal failure and stiffness of the joints and skin. N Engl J Med 358: 827-838, 2008
74. Goldsmith RS, Ingbar SH: Inorganic phosphate treatment of hypercalcemia of diverse etiologies. N Engl J Med 274: 1-7, 1966
75. Ayala G, Chertow BS, Shah JH, Williams GA, Kukreja SC: Acute hyperphosphatemia and acute persistent renal insufficiency induced by oral phosphate therapy [Letter]. Ann Intern Med 83: 520-521, 1975
76. Breuer RI, LeBauer J: Caution in the use of phosphates in the treatment of severe hypercalcemia. J Clin Endocrinol Metab 27: 695-698, 1967
77. Shackney S, Hasson J: Precipitous fall in serum calcium, hypotension, and acute renal failure after intravenous phosphate therapy for hypercalcemia: report of two cases. Ann Intern Med 66: 906-916, 1967
78. Carey RW, Schmitt GW, Kopald HH, Kantrowitz PA: Massive extraskeletal calcification during phosphate treatment of hypercalcemia. Arch Intern Med 122: 150-155, 1968
79. Dudley FJ, Blackburn CR: Extraskeletal calcification complicating oral neutral-phosphate therapy. Lancet 2: 628-630, 1970
80. Hebert LA, Lemann J Jr, Petersen JR, Lennon EJ: Studies of the mechanism by which phosphate infusion lowers serum calcium concentration. J Clin Invest 45: 1886-1894, 1966
81. Sutters M, Gaboury CL, Bennett WM: Severe hyperphosphatemia and hypocalcemia: a dilemma in patient management. J Am Soc Nephrol 7: 2056-2061, 1996
82. Verge CF, Lam A, Simpson JM, Cowell CT, Howard NJ, Silink M: Effects of therapy in X-linked hypophosphatemic rickets. N Engl J Med 325: 1843-1848, 1991
83. Alon U, Donaldson DL, Hellerstein S, Warady BA, Harris DJ: Metabolic and histologic investigation of the nature of nephrocalcinosis in children with hypophosphatemic rickets and in the hyp mouse. J Pediatr 120: 899-905, 1992
84. Stickler GB, Morgenstern BZ: Hypophosphataemic rickets: final height and clinical symptoms in adults. Lancet 2: 902-905, 1989
85. Ettinger DS, Harker WG, Gerry HW, Sanders RC, Saral R: Hyperphosphatemia, hypocalcemia, and transient renal failure: results of cytotoxic treatment of acute lymphoblastic leukemia. JAMA 239: 2472-2474, 1978
86. Boles JM, Dutel JL, Briere J, Mialon P, Robasckiewicz M, Garre M, Briere J: Acute renal failure caused by extreme hyperphosphatemia after chemotherapy of an acute lymphoblastic leukemia. Cancer 53: 2425-2429, 1984
87. Ritskes-Hoitinga J, Lemmens AG, Danse LH, Beynen AC: Phosphorus-induced nephrocalcinosis and kidney function in female rats. J Nutr 119: 1423-1431, 1989
88. Ritskes-Hoitinga J, Mathot JN, Van Zutphen LF, Beynen AC: Inbred strains of rats have differential sensitivity to dietary phosphorus-induced nephrocakinosis. J Nutr 122: 1682-1692, 1992
89. Zager RA: Hyperphosphatemia: a factor that provokes severe experimental acute renal failure. J Lab Clin Med 100: 230-239, 1982
90. Liu-Bryan R, Pritzker K, Firestein GS, Terkeltaub R: TLR2 signaling in chondrocytes drives calcium pyrophosphate dihydrate and monosodium urate crystal-induced nitric oxide generation. J Immunol 174: 5016-5023, 2005
91. Anders HJ, Schlondorff D: Toll-like receptors: emerging concepts in kidney disease. Curr Opin Nephrol Hypertens 16: 177-183, 2007
92. Wynn TA: Cellular and molecular mechanisms of fibrosis. J Pathol 214: 199-210, 2008
93. Boyd AS, Zic JA, Abraham JL: Gadolinium deposition in nephrogenic fibrosing dermopathy. J Am Acad Dermatol 56: 27-30, 2007
94. Rex D, Malik P, Chasen R, Thompson WO, Galt DJB: A randomized, single blind evaluation of oral sodium phosphate solution (OSPS) as bowel preparation with different hydration and dosing regimens [Abstract]. Am J Gastroenterol 101[Suppl]: 504, 2006
95. www.fda.gov/cder/drug/infopage/osp_solution. Accessed May 30, 2008
96. http://www.hc-sc.gc.ca/dhp-mps/medeff/advisories-avis/prof/2005/ phosphate_solutions_2_hpc-cps_e.html. Accessed May 30, 2008
97. http://www.phospho-soda.com/professionals/pdf/ UpdatedRecommendationsOSPS.pdf. Accessed May 30, 2008
98. http://www.fda.gov/cder/drug/infopage/osp_solution/backgrounder.htm. Accessed May 30, 2008
99. Holte K, Nielsen KG, Madsen JL, Kehlet H: Physiologic effects of bowel preparation. Dis Colon Rectum 47: 1397-1402, 2004
100. Markowitz GS, Radhakrishnan J, D'Agati VD: Towards the incidence of acute phosphate nephropathy. J Am Soc Nephrol 18: 3020-3022, 2007
101. Stratta P, Barbieri S, Lazzarich E, Fenoglio R, Quaglia M: Nephrocalcinosis in phosphate nephropathy following oral phosphate purgative: a role for underlying subclinical prirnary hyperparathyroidism? Am J Kidney Dis 50: 1053, 2007; author reply 1053-1054, 2007